Promising early results from #Austria's LEAD-DETECT pilot: of the first 378 people scanned, 4.7% had high-risk #LungNodules detected early. Real-world programmes such as these are building momentum for #LungCancer#Screening across #Europe. Read more👇
https://t.co/exwxV25Rcp
On 27 Aug, @MACAAfricaOrg hosts a webinar on the realities of #LungCancer care throughout #Africa, and how collaboration is bringing focus on the disease and driving progress. We're proud to support our members' work.
Register now via the link. https://t.co/EwfnyTpl9F
#LDCT screening can detect #LungCancer earlier and improve survival, yet access remains inconsistent. Why, and how can we change this?
Screening implementation is a policy choice. Our new advocacy hub exists to help you make clear it’s the obvious one: https://t.co/mbM7YFxFem
Untimely #LungCancer care cost lives. Timed targets can help, but only if they're properly defined, implemented and monitored. Our latest webinar explored how. You can watch the recording now: https://t.co/oyIbbvnTLU
How are #LungCancer policy commitments funded and implemented in practice? Join us at #WCLC2026 for an educational session on financing #LungCancerPolicy, with real‑world examples and practical actions for advocates. Find out more.
https://t.co/yl1NyFfnN0
New research from Sweden: the people at highest risk of #LungCancer may be the least likely to take part in screening.
#Equity must be built in from the start – a programme that misses its highest-risk group isn't yet doing its job.
Read more: https://t.co/0JT9n5akjN
This #WorldLungCancerDay, the evidence on whether screening works is settled – and strong. What's missing now is action. If today moves you to advocate, our new advocacy hub for #LungCancer screening gives you the tools to start: https://t.co/mbM7YFxFem
Today, we’re launching our #Advocacy hub for lung cancer screening: a practical, interactive resource built with insights from our global membership, designed to help advocates make the case for LDCT screening in their own health systems: https://t.co/mbM7YFx7oO
We’re not asking whether #LDCT#Screening works anymore. We know it can transform #LungCancer detection by detecting #Cancer earlier and so improving survival – ultimately delivering long-term value for health systems.
We've refreshed our website, making our evidence, policy insights and practical resources far easier to find and act on. And there's more coming for #Advocates in the weeks ahead, so watch this space!
Explore the new site: https://t.co/xGoaAF6ad9
#PolicyToAction#LungCancer
Policy commitments on #LungCancer are growing. But commitments don't save lives – implementation does.
At #WCLC2026, we're hosting two sessions on turning evidence and commitment into real-world policy action.
Register your interest: https://t.co/yl1NyFfnN0
#PolicyToAction
One year ago, Australia launched its National #LungCancer Screening Program – a major policy endeavour built on evidence, collaboration and a commitment to #Equitable access. So what have we learnt?
Read about Australia’s journey in our case study: https://t.co/ErtBuKFuWv
#LungCancer screening has strong clinical evidence behind it. What's missing is local implementation data – and that gap is holding back scale-up. Help close it by contributing your screening programme or pilot to our global interactive map: https://t.co/FyUPpMw9yL
A new study in Mexico finds delays from symptoms to treatment ranged 5–8 months for 2,600+ people with #LungCancer. Untimely care was driven by misdiagnosis and long travel distances, and the findings underscore point to clear priorities for improvement: https://t.co/9KrAGSjXPs
On Monday: how do we make timely #LungCancer diagnosis and treatment the norm, not the exception? Join our free webinar with experts on the real-world implementation of timed targets, and the barriers that get in the way.
Register: https://t.co/pe9BfkG796
#LungCancer screening has strong evidence behind it. So why have so few European countries moved to national programmes? New analysis finds the bottleneck isn't evidence – it's implementation: funding, workforce and infrastructure.
Read more: https://t.co/71OoP5mEC2
Achieving timely #LungCancer care isn't just a clinical challenge – it requires the right health system and policy conditions. Join our free webinar on Mon 13 July to hear how timed targets can help close the gap.
Register: https://t.co/pe9BfkGEYE
When LDCT screening isn't feasible, what next? A new study shows AI-supported chest X-ray could detect #LungCancer earlier in LMICs – preventing 24,000+ premature deaths over five years across five countries, at cost neutrality.
Find out more: https://t.co/FVXfMWYGx3
We said it yesterday: #LungCancer outcomes depend on timing. Today, the evidence. Our new policy brief makes the case for timed targets – defined time frames for diagnosis and treatment – drawing on case studies from six countries.
Read more: https://t.co/j8oTUF8XtH
#LungCancer outcomes depend on timing, and delays cost lives. Tomorrow, we publish new analysis on this problem. To mark the launch, join our free webinar on Mon 13 July with experts discussing how timed targets drive better care.
Register: https://t.co/pe9BfkG796